FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362541521> ?p ?o ?g. }

• W4362541521 endingPage "3842" @default.
• W4362541521 startingPage "3842" @default.
• W4362541521 abstract "Abstract PDGFR-β (Platelet-Derived Growth Factor Receptor beta) is a receptor tyrosine kinase whose overexpression drives the progression and metastasis of many cancers. It is an established anticancer target and PDGFR-β inhibition via kinase inhibitors has been actively sought-after. However, PDGFR-β kinase inhibitors often lack specificity. The PDGFR-β gene promoter forms DNA G-quadruplexes that are transcription silencer whose stabilization by small molecules represses PDGFR-β expression. Therefore, targeting PDGFR-β promoter G-quadruplexes for transcriptional silencing is a promising alternative strategy for cancer therapy. G-quadruplex is an exciting family of non-canonical DNA secondary structures. DNA G-quadruplex within the PDGFR-β gene promoter forms novel vacancy pockets (vG4) that can be filled-in by guanine metabolites such as dGMP and cGMP. This presents an attractive target for small molecule targeting. Herein, we present the binding of the natural product berberine with the unique PDGFR-β dGMP-vG4 binary complex to form a novel ternary complex, the first case observed in DNA G-quadruplexes. Using circular dichroism, fluorescence, and nuclear magnetic resonance (NMR) spectroscopy, we demonstrated that berberine binds with high affinity and strongly stabilizes the dGMP-fill-in PDGFR-β vG4. Our determined high-resolution NMR structure of this ternary complex in K+-containing solution reveals a 2:1 binding stoichiometry of berberine to the dGMP-fill-in PDGFR-β vG4. Significantly, one berberine directly stacks upon and extensively covers the dGMP. This direct binding mode provides structural basis for targeting the unique PDGFR-β promoter G-quadruplex by small molecules and suggests an intriguing strategy of designing drug-like, guanine-conjugated molecules to selectively silence the PDGFR-β gene. Because vG4 formation and dGMP fill-in is a unique property of the PDGFR-β promoter G-quadruplex, our study provides a structural basis for rationally designing small molecule drugs to specifically target the PDGFR-β promoter G-quadruplex to inhibit oncogenic PDGFR-β for cancer therapeutics. Citation Format: Kai-Bo Wang, Jonathan Dickerhoff, Yichen Han, Danzhou Yang. Berberine recognition of the dGMP-bound PDGFR-β promoter G-quadruplex: Structural insight into specific drug targeting. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 3842." @default.
• W4362541521 created "2023-04-06" @default.
• W4362541521 creator A5012642979 @default.
• W4362541521 creator A5030013482 @default.
• W4362541521 creator A5032920140 @default.
• W4362541521 creator A5042843653 @default.
• W4362541521 date "2023-04-04" @default.
• W4362541521 modified "2023-09-24" @default.
• W4362541521 title "Abstract 3842: Berberine recognition of the dGMP-bound PDGFR-β promoter G-quadruplex: Structural insight into specific drug targeting" @default.
• W4362541521 doi "https://doi.org/10.1158/1538-7445.am2023-3842" @default.
• W4362541521 hasPublicationYear "2023" @default.
• W4362541521 type Work @default.
• W4362541521 citedByCount "0" @default.
• W4362541521 crossrefType "journal-article" @default.
• W4362541521 hasAuthorship W4362541521A5012642979 @default.
• W4362541521 hasAuthorship W4362541521A5030013482 @default.
• W4362541521 hasAuthorship W4362541521A5032920140 @default.
• W4362541521 hasAuthorship W4362541521A5042843653 @default.
• W4362541521 hasConcept C101544691 @default.
• W4362541521 hasConcept C153911025 @default.
• W4362541521 hasConcept C161624437 @default.
• W4362541521 hasConcept C184235292 @default.
• W4362541521 hasConcept C185592680 @default.
• W4362541521 hasConcept C2780116568 @default.
• W4362541521 hasConcept C502942594 @default.
• W4362541521 hasConcept C552990157 @default.
• W4362541521 hasConcept C55493867 @default.
• W4362541521 hasConcept C83762044 @default.
• W4362541521 hasConcept C86803240 @default.
• W4362541521 hasConceptScore W4362541521C101544691 @default.
• W4362541521 hasConceptScore W4362541521C153911025 @default.
• W4362541521 hasConceptScore W4362541521C161624437 @default.
• W4362541521 hasConceptScore W4362541521C184235292 @default.
• W4362541521 hasConceptScore W4362541521C185592680 @default.
• W4362541521 hasConceptScore W4362541521C2780116568 @default.
• W4362541521 hasConceptScore W4362541521C502942594 @default.
• W4362541521 hasConceptScore W4362541521C552990157 @default.
• W4362541521 hasConceptScore W4362541521C55493867 @default.
• W4362541521 hasConceptScore W4362541521C83762044 @default.
• W4362541521 hasConceptScore W4362541521C86803240 @default.
• W4362541521 hasIssue "7_Supplement" @default.
• W4362541521 hasLocation W43625415211 @default.
• W4362541521 hasOpenAccess W4362541521 @default.
• W4362541521 hasPrimaryLocation W43625415211 @default.
• W4362541521 hasRelatedWork W1978018806 @default.
• W4362541521 hasRelatedWork W1980849347 @default.
• W4362541521 hasRelatedWork W2178557128 @default.
• W4362541521 hasRelatedWork W2323449394 @default.
• W4362541521 hasRelatedWork W2483582690 @default.
• W4362541521 hasRelatedWork W2616392253 @default.
• W4362541521 hasRelatedWork W2912941169 @default.
• W4362541521 hasRelatedWork W2950999730 @default.
• W4362541521 hasRelatedWork W3046176750 @default.
• W4362541521 hasRelatedWork W3204105124 @default.
• W4362541521 hasVolume "83" @default.
• W4362541521 isParatext "false" @default.
• W4362541521 isRetracted "false" @default.
• W4362541521 workType "article" @default.